Literature DB >> 27869515

Vi capsular polysaccharide: Synthesis, virulence, and application.

Xiaomei Hu1, Zhijin Chen1, Kun Xiong1, Jing Wang1, Xiancai Rao1, Yanguang Cong1.   

Abstract

Vi capsular polysaccharide, a linear homopolymer of α-1,4-linked N-acetylgalactosaminuronate, is characteristically produced by Salmonella enterica serovar Typhi. The Vi capsule covers the surface of the producing bacteria and serves as an virulence factor via inhibition of complement-mediated killing and promoting resistance against phagocytosis. Furthermore, Vi also represents a predominant protective antigen and plays a key role in the development of vaccines against typhoid fever. Herein, we reviewed the latest advances associated with the Vi polysaccharide, from its synthesis and transport within bacterial cells, mechanisms involved in virulence, immunological characteristics, and applications in vaccine, as well as its purification and detection methods.

Entities:  

Keywords:  Salmonella; Vi; capsular polysaccharide; vaccine; virulence

Mesh:

Substances:

Year:  2016        PMID: 27869515     DOI: 10.1080/1040841X.2016.1249335

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  11 in total

1.  The Benefits of Exporting: Engineered Extracellular Vesicles as Promising Vaccine Candidates against Enteric Fever.

Authors:  Marcio L Rodrigues
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 2.  Salmonella infection: Interplay between the bacteria and host immune system.

Authors:  Jonathan R Kurtz; J Alan Goggins; James B McLachlan
Journal:  Immunol Lett       Date:  2017-07-15       Impact factor: 3.685

3.  Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.

Authors:  Kun Xiong; Chunyue Zhu; Zhijin Chen; Chunping Zheng; Yong Tan; Xiancai Rao; Yanguang Cong
Journal:  Front Cell Infect Microbiol       Date:  2017-04-24       Impact factor: 5.293

4.  Vi-specific serological correlates of protection for typhoid fever.

Authors:  Celina Jin; Jennifer Hill; Bronwyn M Gunn; Wen-Han Yu; Lindsay C Dahora; Elizabeth Jones; Mari Johnson; Malick M Gibani; Rachel L Spreng; S Munir Alam; Anna Nebykova; Helene B Juel; S Moses Dennison; Kelly E Seaton; Jonathan K Fallon; Georgia D Tomaras; Galit Alter; Andrew J Pollard
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

Review 5.  Nucleotide Sugars in Chemistry and Biology.

Authors:  Satu Mikkola
Journal:  Molecules       Date:  2020-12-06       Impact factor: 4.411

Review 6.  Paratyphoid Fever A: Infection and Prevention.

Authors:  Lei Xie; Lan Ming; Manlin Ding; Luxin Deng; Miao Liu; Yanguang Cong
Journal:  Front Microbiol       Date:  2022-07-08       Impact factor: 6.064

7.  Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.

Authors:  Celina Jin; Malick M Gibani; Maria Moore; Helene B Juel; Elizabeth Jones; James Meiring; Victoria Harris; Jonathan Gardner; Anna Nebykova; Simon A Kerridge; Jennifer Hill; Helena Thomaides-Brears; Christoph J Blohmke; Ly-Mee Yu; Brian Angus; Andrew J Pollard
Journal:  Lancet       Date:  2017-09-28       Impact factor: 79.321

Review 8.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

Review 9.  Glyconanoparticles as tools to prevent antimicrobial resistance.

Authors:  Laura Morelli; Laura Polito; Barbara Richichi; Federica Compostella
Journal:  Glycoconj J       Date:  2021-03-17       Impact factor: 2.916

10.  A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination.

Authors:  Elizabeth Jones; Celina Jin; Lisa Stockdale; Christina Dold; Andrew J Pollard; Jennifer Hill
Journal:  Microorganisms       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.